The Vanguard Group, Inc. recently announced the acquisition of new stake in Intuitive Surgical Inc. (NASDAQ:ISRG). The institutional investor has increased its shareholding in the Healthcare company by 0.47% to 27.94 million shares with purchase of 0.13 million shares. This fresh investment now brings its stake to 7.98% valued currently at $6.41 billion. In addition, BlackRock Fund Advisors raised its holdings by 31244.0 to 16.61 million shares. And Capital Research & Management Co has lifted its position by 0.65% or 47782.0 shares – to 7.44 million shares.
With over 2.11 million Intuitive Surgical Inc. (ISRG) shares trading Tuesday and a closing price of $235.28 on the day, the dollar volume was approximately $496.19 million. The shares have shown a positive half year performance of 5.97% and its price on 03/14/23 gained nearly 3.29%. Currently, there are 351.20M common shares owned by the public and among those 348.62M shares have been available to trade.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
Sponsored
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 24 analysts who have offered their price forecasts for ISRG have a consensus price objective of $277.47. The analysts have set the share’s price value over the next 12 months at a high of $325.00 and a low of $215.00. The average price target is 15.67% above its recent price level and a downside to the estimated low will see the stock lose -9.43% over that period. But an upside of 27.61% will see the stock hit the forecast high price target while median target price for the stock is $285.00.
Insiders at the company have transacted a total of 51 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 29 of these insider trades were purchases, accounting for 306,976 shares. Insider sales of the common stock occurred on 22 occasions, with total insider shares sold totaling 223,560 shares.
The top 3 mutual fund holders in Intuitive Surgical Inc. are Vanguard Total Stock Market Index, Vanguard 500 Index Fund, and Invesco QQQ Trust. Vanguard Total Stock Market Index owns 10.83 million shares of the company’s stock, all valued at over $2.49 billion. The company bought an additional 85069.0 shares recently to bring their total holdings to about 3.09% of the shares outstanding. Vanguard 500 Index Fund bought 19407.0 shares to see its total holdings expand to 8.19 million shares valued at over $1.88 billion and representing 2.34% of the shares outstanding. Invesco QQQ Trust sold 15984.0 shares to bring its total holdings to over 4.58 million shares at a value of $1.05 billion. Invesco QQQ Trust now owns shares totaling to 1.31% of the shares outstanding.
Shares of Intuitive Surgical Inc. (NASDAQ: ISRG) opened at $232.54, up $4.76 from a prior closing price of $227.78. However, the script later moved the day high at 235.62, up 3.29%. The company’s stock has a 5-day price change of 1.98% and -13.05% over the past three months. ISRG shares are trading -11.33% year to date (YTD), with the 12-month market performance down to -14.03% lower. It has a 12-month low price of $180.07 and touched a high of $308.97 over the same period. ISRG has an average intraday trading volume of 1.75 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 0.70%, -4.91%, and 1.92% respectively.
Institutional ownership of Intuitive Surgical Inc. (NASDAQ: ISRG) shares accounts for 86.60% of the company’s 351.20M shares outstanding. Mutual fund holders own 34.12%, while other institutional holders and individual stakeholders account for 51.96% and 1.38% respectively.
It has a market capitalization of $83.84B and a beta (3y monthly) value of 1.29. The stock’s trailing 12-month PE ratio is 64.42, while the earnings-per-share (ttm) stands at $3.65. The company has a PEG of 4.44 and a Quick Ratio of 3.80 with the debt-to-equity ratio at 0.00. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.79% over the week and 2.06% over the month.
Analysts forecast that Intuitive Surgical Inc. (ISRG) will achieve an EPS of $1.2 for the current quarter, $1.31 for the next quarter and $6.22 for 2024. The lowest estimate earnings-per-share for the quarter is $1.12 while analysts give the company a high EPS estimate of $1.25. Comparatively, EPS for the current quarter was $1.13 a year ago. Earnings per share for the fiscal year are expected to decrease by -21.60%, and 17.28% over the next financial year. EPS should grow at an annualized rate of 14.49% over the next five years, compared to 5.20% over the past 5-year period.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 24 brokerage firm advisors rate Intuitive Surgical Inc. (ISRG) as a “Moderate Buy” at a consensus score of 2.20. Specifically, 11 Wall Street analysts polled rate the stock as a buy, while 10 of the 24 advise that investors “hold,” and 0 rated it as a “Sell.”
Looking at the support for the ISRG, a number of firms have released research notes about the stock. Barclays stated their Overweight rating for the stock in a research note on October 18, 2022, with the firm’s price target at $235. Mizuho coverage for the Intuitive Surgical Inc. (ISRG) stock in a research note released on October 13, 2022 offered a Neutral rating with a price target of $215. Jefferies was of a view on October 12, 2022 that the stock is Hold, while Truist gave the stock Buy rating on April 13, 2022, issuing a price target of $360. Wolfe Research on their part issued Peer Perform rating on April 06, 2022.
